NCT00004209View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

PHASE3UnknownINTERVENTIONAL

Timeline

Start Date

May 31, 1998

Conditions

Lung Cancer

Interventions

DRUG

cisplatin

DRUG

mitomycin C

DRUG

vinblastine sulfate

Trial Locations (2)

SW3 6JJ

Royal Marsden NHS Trust, London

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

Sponsors

Lead Sponsor

Cancer Research UK

All Listed Sponsors

lead

Cancer Research UK

OTHER

NCT00004209 - Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter